tiprankstipranks
Positive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages
PremiumRatingsPositive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages
29d ago
Janux Therapeutics Reports Strong Financial Position and Clinical Progress
Premium
Company Announcements
Janux Therapeutics Reports Strong Financial Position and Clinical Progress
1M ago
Janux Therapeutics price target lowered to $41 from $62 at Scotiabank
Premium
The Fly
Janux Therapeutics price target lowered to $41 from $62 at Scotiabank
1M ago
Janux Therapeutics names Zachariah McIver, D.O., Ph.D. as Chief Medical Officer
PremiumThe FlyJanux Therapeutics names Zachariah McIver, D.O., Ph.D. as Chief Medical Officer
2M ago
Opco lists five potential biotech targets into JPMorgan conference
Premium
The Fly
Opco lists five potential biotech targets into JPMorgan conference
3M ago
Janux Therapeutics CEO sells $1.4M in common stock
Premium
The Fly
Janux Therapeutics CEO sells $1.4M in common stock
3M ago
Morning Movers: U.S. Steel falls following Trump vow to block Nippon deal
PremiumThe FlyMorning Movers: U.S. Steel falls following Trump vow to block Nippon deal
4M ago
Vir has positive readthrough from Janux data, says Morgan Stanley
Premium
The Fly
Vir has positive readthrough from Janux data, says Morgan Stanley
4M ago
Janux Therapeutics price target raised to $115 from $70 at Stifel
Premium
The Fly
Janux Therapeutics price target raised to $115 from $70 at Stifel
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100